To investigate the expression and assess the potential as biomarkers and treatment targets of EGFR, MPS-1, Aurora-B, and KSP in HNSCC patients, we explored both the UALCAN and GEPIA databases. Here, AURKB is linked to head and neck squamous cell carcinoma.